Search results
FDA approves self-tests for cervical cancer, as an alternative to the dreaded pelvic exam
USA TODAY via Yahoo News· 14 minutes agoOffering options like self-screening can build trust between providers and patients from...
FDA: Avoid These Dairy Products During the Current Bird Flu Outbreak
Prevention· 7 days agoThe FDA reported which dairy products are safe to eat amid the recent bird flu outbreak. Bird flu...
FDA issues recall notice for Philips after another respiratory device fails
Medical Device Network via Yahoo Finance· 2 hours agoThe FDA has issued the notice for the company’s Trilogy EVO Continuous Ventilators, warning that...
The Forces Weighing Against FDA Bans on Toxic Ingredients
Bloomberg· 3 hours agoGood morning, it’s Fiona in New York. The FDA has missed a deadline for a proposed ban on a...
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 17 hours agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S....
FDA said it "never" inspected dental lab that made controversial AGGA device
CBS News· 2 days agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
FDA issues ‘most serious type of recall’ involving app-reliant insulin pumps
WPIX New York City, NY via Yahoo News· 1 day agoThe U.S. Food and Drug Administration has issued a recall correction for an Apple iOS app used with...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via AOL· 18 hours agoU.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator...
FDA warns users not to use Cue Health’s at-home Covid-19 tests
Medical Device Network via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has warned users not to use Cue Health’s at-home Covid-19...
... Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for...
Fort Wayne Journal Gazette· 13 hours agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation ...